Likewise, the proportion of CD8+IFN-γ+ cells increased approximately 4-fold with the combined treatment compared to untreated controls (Figure 7C for MOC2 tumor, Figure S5D for 4T1 tumors), indicating a strong Th1 differentiation phenotype with anti-VISTA and RT. Here, CD8A is linked to neoplasm.